1 / 4

Global Oncology Drugs Market 2018-2024 - Drivers, Restraints, Opportunities, Trends, and Forecasts up to 2024

Immunotherapies/ biologics are emerging as potential therapies to find the permanent cure for various cancer types. Amongst various biologics, drugs based on monoclonal antibodies (mAbs) have gained significant attention in recent years due to their high efficacy.<br><br>Download a free sale report here @ https://axiommrc.com/request-for-sample/?report=1397<br>

raunny0926
Download Presentation

Global Oncology Drugs Market 2018-2024 - Drivers, Restraints, Opportunities, Trends, and Forecasts up to 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Oncology Drugs Market Report, By Therapeutic Modules, Cancer Type and Geography – Global Market Share, Trend Analysis and Forecast up to2024 Email:sales@axiommrc.com

  2. The global oncology drugs market revenue is estimated to reach USD 202.13 Billion by 2024 expanding at a CAGR of 7.8% from 2019 to2024. Immunotherapies/ biologics are emerging as potential therapies to find the permanent cure for various cancer types. Amongst various biologics, drugs based on monoclonal antibodies (mAbs) have gained significant attention in recent years due to their highefficacy. Key driving factors of the Oncology drugmarket: The cancer drugs market is driven by the growing prevalence of various types of cancer, increasing demand of biological and targeted drug therapies, continuous patent expiry of keycancer drugs and the rising impact of biosimilars.However,thehighcostofdrugdevelopment,thethreatoffailure and the adverse effects of cancer drug therapy, particularly chemotherapy, hinders the market growth. Developed nations haveimplemented strict regulations for the design and development of cancer drugs. USFDA and European Union have undertaken significant initiatives to fuel the growth of the cancer drugs market by providing pre-market approval for potentialdrugs under clinicaldevelopment. Download a free sale report here @ https://axiommrc.com/request-for- sample/?report=1397 The global oncology drugs market is segmented on the basis of therapeutic modules, cancer type andgeography. Based on the therapeuticmodules: Themarket is segmented into chemotherapy, targeted therapy, immunotherapy, hormonal therapy andothers. On the basis of cancertype: The global oncology drugs market is segmented into blood cancer, breast cancer, gastrointestinal cancer, prostate cancer, lung cancer, skin cancer and others.

  3. Bygeography: The market is fragmented into North America, Europe, Asia Pacific, Middle East and Africa and Latin America. North America is anticipated to remain the leadingregionovertheforecastperiodfrom2018to2024.Demandforcancer drugs was highest in North America especially in theU.S. Get more detail about this report @ https://axiommrc.com/speak-to- analyst/?report=1397 North America dominates the market for cancer drugs as the region houses companies engaged in the development of cancer drugs. Additionally, the disposable incomes of consumers and health insurance cover for life- threatening diseases in North America are very high which increases the affordability of cancer treatment. In recent years, US Food and Drug Administration (USFDA) has taken initiatives to support the growth of cancer drugs market by providing pre-market approval to the drugs, which are in the clinical phase; thus, accelerating the clinical development. Asia Pacific is expected to be the moderate growing region in cancer drugs market during the forecast period. Moreover, the Middle East and Africa and Latin America are also expected to show moderate growth for this market in the years to come. Buy this report @https://axiommrc.com/buy-now/? Some of the key players operating in the oncology drugs market with most significant product development include and are not limited to Amgen Inc., Johnson and Johnson, Roche Diagnostics, GlaxoSmithKline PLC, Merck & Company, Novartis AG, Pfizer, Sanofi, Eli Lilly and Company, Celgene Corporation, Bayer, Amgen, Merck, Bristol-Myers Squibb, Ariad Pharmaceuticals, Hoffmann-La Roche Ltd, Boehringer Ingelheim GmbH, and Teva Pharmaceuticals amongothers.

  4. AboutUs: Axiom Market Research & Consulting™ (also known as Axiom MRC), is a full- service market research and data analytics firm, driven by a simple aim of providing key market intelligence to companies to assist them in taking informed business decisions pertaining to their marketing strategy, investments, new product launches, market competition, consumer or end users, social media trendsetc. ContactUs UnitedStates 616 Corporate Way, Suite2-4268 Valley Cottage, NY10989 Telephone: +1 (845) 875-9786 Email:sales@axiommrc.com

More Related